LBP-025 Once-monthly efimosfermin alfa in participants with metabolic dysfunction-associated steatohepatitis with F2/F3 fibrosis: post hoc results from a 24-week, randomized, double-blind, placebocontrolled, phase 2 trial
作者
Rohit Seth Loomba,Kris V. Kowdley,Muhammad Y. Sheikh,Nomita Kim,Anita Kohli,Eric Lawitz,Brenda I. Jeglinski,Kelly Kutch,Jose Manuel Trigo,Patricia Mendez,Margaret James Koziel,Stuart Kendrick,Sumanta Mukherjee,Mazen Noureddin